These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21486193)

  • 21. The human hepatic cytochromes P450 involved in drug metabolism.
    Wrighton SA; Stevens JC
    Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
    Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
    Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug metabolism and pharmacokinetics in drug discovery.
    Roberts SA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using in vitro human tissues to predict pharmacokinetic properties.
    Huebert ND; Dasgupta M; Chen Y
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):69-74. PubMed ID: 14982150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the transport properties of metabolites: case studies and considerations for drug development.
    Zamek-Gliszczynski MJ; Chu X; Polli JW; Paine MF; Galetin A
    Drug Metab Dispos; 2014 Apr; 42(4):650-64. PubMed ID: 24346835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychophysiological stress: a significant parameter in drug pharmacokinetics.
    Konstandi M
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1317-34. PubMed ID: 23834396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development.
    Di L; Feng B; Goosen TC; Lai Y; Steyn SJ; Varma MV; Obach RS
    Drug Metab Dispos; 2013 Dec; 41(12):1975-93. PubMed ID: 24065860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro methods to study the interplay of drug metabolism and efflux in the intestine.
    Siissalo S; Heikkinen AT
    Curr Drug Metab; 2013 Jan; 14(1):102-11. PubMed ID: 22497570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics.
    Smith DA; Jones BC; Walker DK
    Med Res Rev; 1996 May; 16(3):243-66. PubMed ID: 8727426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro methods in the prediction of kinetics of drugs: focus on drug metabolism.
    Raunio H; Taavitsainen P; Honkakoski P; Juvonen R; Pelkonen O
    Altern Lab Anim; 2004 Oct; 32(4):425-30. PubMed ID: 15651928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolites: structure determination and prediction.
    Cruciani G
    Drug Discov Today Technol; 2013; 10(1):e145-6. PubMed ID: 24050243
    [No Abstract]   [Full Text] [Related]  

  • 36. [Application of real-time PCR to pharmacokinetic studies].
    Wyska E; Rosiak M
    Postepy Hig Med Dosw (Online); 2006; 60():660-6. PubMed ID: 17245316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phoenix rises: a new science of in vivo drug metabolism. Preface.
    Samuelsson K; Wilson ID
    Xenobiotica; 2014 Jan; 44(2):95. PubMed ID: 24447193
    [No Abstract]   [Full Text] [Related]  

  • 38. Theoretical pharmacokinetic drug alterations in pediatric celiac disease.
    Tran TH; Smith C; Mangione RA
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1539-50. PubMed ID: 26155875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric pharmacokinetics: human development and drug disposition.
    Funk RS; Brown JT; Abdel-Rahman SM
    Pediatr Clin North Am; 2012 Oct; 59(5):1001-16. PubMed ID: 23036241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How drug metabolism influences treatment outcomes.
    Brown CA; Brown JY; Coleman MD
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):913-5. PubMed ID: 18028033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.